A Preview Of This Week's 8 IPOs: Biotechs Rule The Roost

On Wednesday, three stocks will make their market debut.

• AnaptysBio(NASDAQ: ANAB) is a biotechnology company specializing in antibody development. It will issue will 4,000,000 shares between $14 and $16.
• AppDynamics (NASDAQ: APPD) allows businesses to monitor their digital space and performance. About 12,000,000 shares will be offered between $10 and $12.
• ObsEva (NASDAQ: OBSV) — a clinical-stage biopharmaceutical company focusing on women’s reproductive health — will issue 6,450,000 shares between $14 and $16.

The next five IPOs will hit the market Thursday.

• Jagged Peak Energy (NYSE: JAG), an oil and natural gas producer, will offer 38,225,000 shares between $16 and $18.
• JELD-WEN Holding (NYSE: JELD) — a company specializing in windows and doors — will issue 25,000,000 shares between $21 and $23.
• Jounce Therapeutics Inc. (NASDAQ: JNCE), a cancer-treatment developer, collaborates with present public companies such as Celgene Corporation (NASDAQ: CELG). About 5,360,000 shares will be issued between $13 and $15 .
• REV Group (NYSE: REVG) is the parent of 27 vehicle brands from ambulances to RVs. Its 12,500,000 shares will hit the market between $19 and $21.
• Visterra (NASDAQ: VIST) is a clinical-stage biopharmaceutical company developing treatments for diseases ranging from influenza A to zika. About 3,850,000 shares will be offered between $12 and $14.